出版社 | MarketsandMarkets |
出版年月 | 2025年5月 |
Electronic Clinical Outcome Assessment (eCOA) Solutions Market – Global Forecast to 2030
- 本レポートは、電子臨床アウトカム評価(eCOA)ソリューション市場を、コンポーネント、製品、導入モデル、アプリケーション、エンドユーザー、地域の観点から分析しています。
- 本レポートでは、市場の成長に影響を与える要因(推進要因、制約要因、機会、課題)を分析しています。
- 本レポートでは、ステークホルダーにとっての市場の機会と課題を評価し、市場リーダーの競争環境を詳細に説明しています。
- 本レポートでは、マイクロ市場の成長傾向、見通し、そして電子臨床アウトカム評価(eCOA)ソリューション市場全体への貢献について調査しています。
- 本レポートでは、5つの主要地域における市場セグメントの収益予測を行っています。
The electronic clinical outcome assessment (eCOA) solutions market is projected to reach USD 4.78 billion by 2030 from USD 2.27 billion in 2025, at a CAGR of 16.1% during the forecast period. The growing inclination towards digital data collection and analysis, an escalating need for economic data collection solutions, and the increasing integration of connected devices in healthcare institutions are the factors that will drive the growth of this market. On the other hand, the sensitivity of patient health data requires robust security measures. Concerns about data breaches, unauthorized access, or cybersecurity threats may impede the adoption of eCOA solutions to a certain extent over the forecast period.
電子臨床アウトカム評価(eCOA)ソリューション市場は、2025年の22億7,000万米ドルから2030年には47億8,000万米ドルに達し、予測期間中は年平均成長率(CAGR)16.1%で成長すると予測されています。デジタルデータ収集・分析への関心の高まり、経済的データ収集ソリューションへのニーズの高まり、医療機関におけるコネクテッドデバイスの統合拡大が、この市場の成長を牽引する要因となるでしょう。一方で、患者の健康データは機密性が高いため、堅牢なセキュリティ対策が求められます。データ漏洩、不正アクセス、サイバーセキュリティの脅威への懸念は、予測期間中、eCOAソリューションの導入をある程度阻害する可能性があります。
Key Players
The prominent players in this market are IQVIA (US), Medidata (US), ICON Plc (Ireland), Signant Health (US), Clario (US), Oracle Corporation (US), Medable Inc. (US), Merative (US), Parexel International (MA) Corporation (US), Climedo Health GmbH (Germany), Healthentia (Belgium), Veeva Systems (US), assisTek (US), Curebase Inc. (US), Castor (US), EvidentIQ Group GmbH (Germany), YPrime, LLC (US), Clinical Ink (US), Clinion (US), Kayentis (France), TransPerfect (US), ObvioHealth USA, Inc. (US), WCG Clinical (Germany), ClinCapture (US), and Cloudbyz (US). Players adopted organic as well as inorganic growth strategies such as product launches and enhancements, and investments, partnerships, collaborations, joint ventures, funding, acquisition, expansions, agreements, contracts, and alliances to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

This report provides insights into the following pointers:
Analysis of key drivers (Increasing R&D expenditure for product development by medtech and pharma-biotech companies, the rising operational costs and regulatory requirements associated with clinical research studies, favorable government support and funding for clinical trials, growing prevalence of chronic diseases and subsequent increase in clinical trials, effective monitoring of clinical data, reduction in overall costs and timelines of clinical trials), restraints (shortage of skilled professionals to develop and operate eCOA solutions, high implementation and maintenance cost, lack of awareness regarding eCOA solutions among end users), opportunities (surging eCOA adoption owing to increasing number of clinical trials in emerging economies, growing outsourcing of clinical trial processes to CROs, gradual shift from manual data interpretation to real-time data analysis, increasing penetration of mobile technology in healthcare industry), and challenges (evolving regulatory landscape and compliance requirements, lack of interoperability & integration, concerns regarding data security & privacy, resistance from traditional healthcare professionals and concerns regarding software reliability) influencing the growth of electronic clinical outcome assessment (eCOA) solutions market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the electronic clinical outcome assessment (eCOA) solutions market.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various electronic clinical outcome assessment (eCOA) solutions across regions.
- Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the electronic clinical outcome assessment (eCOA) solutions market.
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the electronic clinical outcome assessment (eCOA) solutions market.